Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RIPK4 is associated with altered bioenergetics and invasive in melanoma three-dimensional models.

Scientific reports·2026
Same author

RIPK4 function interferes with melanoma cell adhesion and metastasis.

Molecular oncology·2026
Same author

Correction: Möller et al. Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma Cells. <i>Int. J. Mol. Sci.</i> 2023, <i>24,</i> 14947.

International journal of molecular sciences·2025
Same author

Healthy microbiome-moving towards functional interpretation.

GigaScience·2025
Same author

The vitamin D<sub>3</sub> hormone, 1,25(OH)<sub>2</sub>D<sub>3</sub>, regulates fibroblast growth factor 23 (FGF23) production in human skin cells.

American journal of physiology. Cell physiology·2025
Same author

HCS-hierarchical algorithm for simulation of omics datasets.

Bioinformatics (Oxford, England)·2024

Related Experiment Video

Updated: Sep 5, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K

Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients.

Radosław Piliszek1, Anna A Brożyna2, Witold R Rudnicki1,3

  • 1Computational Centre, University of Białystok, ul. Konstantego Ciołkowskiego 1M, 15-245 Białystok, Poland.

International Journal of Molecular Sciences
|July 9, 2022
PubMed
Summary

Researchers identified seven key biomarkers for diagnosing bladder cancer, specifically carcinoma in situ (CIS). This discovery offers a simpler, more cost-effective diagnostic approach compared to current methods.

Keywords:
biomarker identificationcarcinoma in situ (CIS)nonmuscle-invasive bladder cancer (NMIBC)optimal feature set selection

More Related Videos

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.8K
Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

13.9K

Related Experiment Videos

Last Updated: Sep 5, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K
Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.8K
Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

13.9K

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Genomics

Background:

  • Carcinoma in situ (CIS) of the bladder presents diagnostic challenges with poor prognosis.
  • Limited research exists on biomarkers crucial for CIS development and progression.
  • Omics data, like gene expression, yields numerous potential variables for analysis.

Purpose of the Study:

  • To develop a novel feature selection method for omics data in bladder cancer.
  • To identify a minimal set of high-quality biomarkers for CIS diagnostics.
  • To enable interpretable insights into bladder cancer data.

Main Methods:

  • Analysis of an omics dataset from bladder cancer patients, primarily non-muscle-invasive bladder cancer (NMIBC).
  • Application of a novel feature selection approach designed for high-dimensional data.
  • Validation of selected features for predictive accuracy and biological relevance.

Main Results:

  • A highly effective feature selection method was developed.
  • A small, curated set of seven key biomarkers for bladder cancer diagnostics was identified.
  • The identified biomarkers offer potential for developing new diagnostic tests.

Conclusions:

  • The novel feature selection approach successfully identified crucial biomarkers for bladder cancer.
  • These seven biomarkers can potentially form the basis of new, efficient diagnostic tests.
  • This research provides a foundation for improved bladder cancer diagnosis and management.